A Phase 2b/3, Multicenter, Randomized, Double-masked, Vehicle-controlled Clinical Study to Assess the Efficacy and Safety of Topical CyclASol® for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) (ESSENCE Trial)
Phase of Trial: Phase II/III
Latest Information Update: 21 Dec 2017
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Acronyms ESSENCE Trial
- Sponsors Novaliq
- 09 Nov 2017 According to a Novaliq media release, randomization of patients has been begun.
- 27 Oct 2017 Status changed from not yet recruiting to recruiting.
- 29 Sep 2017 New trial record